Home > News & Advocacy > Neurosurgery Watch > Stereotactic & Functional

Stereotactic & Functional

Read the latest findings in Neurosurgery Watch related to stereotactic and functional neurosurgery and improve your practice with new approaches and techniques.

SF
TU

Stereotactic radiosurgery alone for patients with up to 10 brain metastases

April 30, 2014
Stereotactic & Functional, Tumor
By: 
Clark C. Chen, MD PhD
Source: 
Lancet Oncology

The role of stereotactic radiosurgery (SRS) for patients with multiple metastases remains uncertain.  A prospective observational study published in Lancet Oncology evaluates the use of SRS without addition of whole brain irradiation on survival for 1194 patients (KPS>70) with 1-10...

SF
TU

Predicting Overall Survival for Patients After Radiosurgery for Brain Metastases

February 3, 2014
Stereotactic & Functional, Tumor
By: 
Gavin P. Dunn, MD PhD
Gabriel Zada, MD
Source: 
Journal of Neurosurgery

Difficulties in predicting survival for brain metastasis patients is underappreciated and has ramifications for cost-effective care. Kondziolka et al. assessed the ability of clinicians to predict survival in 150 cancer patients undergoing stereotactic radiosurgery for brain metastases from 2009-11. Clinicians...

SF
TU

Resection Bed Radiosurgery Improves Local Control for Brain Metastases

February 3, 2014
Stereotactic & Functional, Tumor
By: 
Jonathan Sherman, MD
J. Bradley Elder, MD
Source: 
http://journals.lww.com/neurosurgery/Abstract/2013/12000/Predicting_Tumor_Contro...

Current management of brain metastases frequently involves stereotactic radiosurgery (SRS) and/or whole brain radiation therapy (WBRT) after surgery. This study examines factors associated with SRS to the surgical bed after brain metastasis resection. Overall, 86% of 120 patients achieved local...

SF
TU

Radiosurgical Management of Non-Functional Pituitary Adenomas

October 1, 2013
Stereotactic & Functional, Tumor
By: 
Gavin P. Dunn, MD PhD
Gabriel Zada, MD
Source: 
Journal of Neurosurgery

The North American Gamma Knife Consortium reported outcomes following gamma knife radiosurgery (GKRS) for nonfunctioning pituitary adenomas in 512 patients (93.6% with prior surgical resection) with median 36 months followup (range 1-223 months) and median tumor margin dose of 16...

Pages

Find a Neurosurgeon